TME Pharma (France) Performance
| ALTME Stock | 0.15 0.01 7.14% |
On a scale of 0 to 100, TME Pharma holds a performance score of 3. The entity has a beta of 0.53, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, TME Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding TME Pharma is expected to be smaller as well. Please check TME Pharma's potential upside, rate of daily change, and the relationship between the sortino ratio and skewness , to make a quick decision on whether TME Pharma's existing price patterns will revert.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in TME Pharma NV are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, TME Pharma reported solid returns over the last few months and may actually be approaching a breakup point. ...more
TME |
TME Pharma Relative Risk vs. Return Landscape
If you would invest 14.00 in TME Pharma NV on August 26, 2024 and sell it today you would earn a total of 1.00 from holding TME Pharma NV or generate 7.14% return on investment over 90 days. TME Pharma NV is generating 0.2662% of daily returns and assumes 5.7077% volatility on return distribution over the 90 days horizon. Simply put, 50% of stocks are less volatile than TME, and 95% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
TME Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for TME Pharma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as TME Pharma NV, and traders can use it to determine the average amount a TME Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0466
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ALTME | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.71 actual daily | 50 50% of assets are less volatile |
Expected Return
| 0.27 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average TME Pharma is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of TME Pharma by adding it to a well-diversified portfolio.
Things to note about TME Pharma NV performance evaluation
Checking the ongoing alerts about TME Pharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for TME Pharma NV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| TME Pharma NV had very high historical volatility over the last 90 days | |
| TME Pharma NV has some characteristics of a very speculative penny stock |
- Analyzing TME Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether TME Pharma's stock is overvalued or undervalued compared to its peers.
- Examining TME Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating TME Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of TME Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of TME Pharma's stock. These opinions can provide insight into TME Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for TME Stock Analysis
When running TME Pharma's price analysis, check to measure TME Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TME Pharma is operating at the current time. Most of TME Pharma's value examination focuses on studying past and present price action to predict the probability of TME Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TME Pharma's price. Additionally, you may evaluate how the addition of TME Pharma to your portfolios can decrease your overall portfolio volatility.